Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions

OncoImmunology

Volumn 5, Issue 1, 2016, Pages

  Thibaudin, Marion ^a,b   Chaix, Marie ^c   Boidot, Romain ^a,b,c   Végran, Frédérique ^a,b,c   Derangère, Valentin ^a,b   Limagne, Emeric ^a,b   Berger, Hélène ^a,b   Ladoire, Sylvain ^a,b,c   Apetoh, Lionel ^a,b,c   Ghiringhelli, François ^a,b,c  

^a Institut Médical de Génétique et d Immunologie   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Breast cancer; Ectonucleotidase; Prognosis; Th17

Indexed keywords

ADENOSINE; ALPHA INTERFERON; ANTHRACYCLINE; CD39 ANTIGEN; CHEMOKINE RECEPTOR CCR6; DEOXYRIBONUCLEASE; ECTONUCLEOTIDASE; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATASE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; T CELL CULTURE; TH17 CELL; WESTERN BLOTTING;

EID: 84954445186     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1055444     Document Type: Article

References (26)

1. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40; PMID:15657292; http://dx. doi. org/10. 1084/jem. 20041257
2. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27:485-517; PMID:19132915; http://dx. doi. org/10. 1146/annurev. immunol. 021908. 132710
3. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8:639-46; PMID:17486092; http:// dx. doi. org/10. 1038/ni1467
4. Chalmin F, Mignot G, Bruchard M, Chevriaux A, Vegran F, Hichami A, Ladoire S, Derangère V, Vincent J, Masson D et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppres activity via the regulation of ectonucleotidase expression. Immunity 2012; 36:362-73; PMID:22406269; http://dx. doi. org/ 10. 1016/j. immuni. 2011. 12. 019
5. Zhang JP, Yan J, Xu J, PangXH, ChenMS, LiL, WuC, Li SP, Zheng L. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 2009; 50:980-9; PMID:19329213; http://dx. doi. org/10. 1016/j. jhep. 2008. 12. 033
6. Chen X, Wan J, Liu J, Xie W, Diao X, Xu J, Zhu B, Chen Z. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 2010; 69:348-54; PMID:20022135; http://dx. doi. org/10. 1016/j. lungcan. 2009. 11. 013
7. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; http://dx. doi. org/10. 1158/0008-5472. CAN-10-2907
8. Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011; 35:972-85; PMID:22177921; http://dx. doi. org/ 10. 1016/j. immuni. 2011. 09. 019
9. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114:1141-9; PMID:19470694; http://dx. doi. org/10. 1182/blood-2009-03-208249
10. Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 2013; 19:57-64; PMID:23202296; http://dx. doi. org/10. 1038/nm. 2999
11. Chung AS, Wu X, Zhuang G, Ngu H, Kasman I, Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 2013; 19:1114-23; PMID:23913124; http://dx. doi. org/10. 1038/nm. 3291
12. Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med 2007; 27:469-85, v; PMID:17658403; http://dx. doi. org/ 10. 1016/j. cll. 2007. 05. 002
13. Saze Z, Schuler PJ, Hong CS, Cheng D, Jackson EK, Whiteside TL. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 2013; 122:9-18; PMID:23678003; http://dx. doi. org/10. 1182/blood-2013-02-482406
14. Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D et al. Human CD4 CD39 regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73 exosomes or CD73 cells. Clin Exp Immunol 2014; 177(2):531-43; PMID:24749746; http://dx. doi. org/10. 1111/ cei. 12354
15. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Harasymczuk M, Mandapathil M, Lang S, Jackson EK et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-65; PMID:17502665; http://dx. doi. org/10. 1084/ jem. 20062512
16. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 1991; 12:42-9; PMID:1999122; http://dx. doi. org/10. 1002/cyto. 990120107
17. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008; 180:214-21; PMID:18097022; http://dx. doi. org/ 10. 4049/jimmunol. 180. 1. 214
18. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Ggrowth Factor Rev 2003; 14:409-26; PMID:12948524; http://dx. doi. org/10. 1016/S1359-6101(03)00049-2
19. Chen WC, Lai YH, Chen HY, Guo HR, Su IJ, Chen HH. Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology 2013; 63:225-33; PMID:23738752; http://dx. doi. org/10. 1111/his. 12156
20. Xu L, Xu W, Qiu S, Xiong S. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer. Clin Immunol 2010; 135:466-75; PMID:20181533; http://dx. doi. org/ 10. 1016/j. clim. 2010. 01. 014
21. Longhi MS, Moss A, Bai A, Wu Y, Huang H, Cheifetz A, Quintana FJ, Robson SC. Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease. PloS One 2014; 9:e87956; PMID:24505337; http://dx. doi. org/10. 1371/journal. pone. 0087956
22. Valmori D, Raffin C, Raimbaud I, Ayyoub M. Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineagespecific polarizing factors. Proc Natl Acad Sci U S A 2010; 107:19402-7; PMID:20962281; http://dx. doi. org/10. 1073/pnas. 1008247107
23. Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P, Ghiringhelli F. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res 2008; 14:2413-20; PMID:18413832; http:// dx. doi. org/10. 1158/1078-0432. CCR-07-4491
24. Ladoire S, Mignot G, Dabakuyo S, Arnould L, Apetoh L, Rebe C, Coudert B, Martin F, Bizollon MH, Vanoli A et al. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol 2011; 224:389-400; PMID:21437909; http://dx. doi. org/10. 1002/path. 2866
25. Helenius M, Jalkanen S, Yegutkin G. Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochim Biophys Acta 2012; 1823:1967-75; PMID:22967714; http:// dx. doi. org/10. 1016/j. bbamcr. 2012. 08. 001
26. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z, Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009; 25:1091-3; PMID:19237447; http://dx. doi. org/ 10. 1093/bioinformatics/btp101